Key statistics
On Friday, VIVA Biotech Holdings (1873:HKG.HS) closed at 2.31, -29.36% below its 52-week high of 3.27, set on Oct 08, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 2.35 |
|---|---|
| High | 2.35 |
| Low | 2.25 |
| Bid | 2.28 |
| Offer | 2.31 |
| Previous close | 2.36 |
| Average volume | 7.51m |
|---|---|
| Shares outstanding | 2.13bn |
| Free float | 1.21bn |
| P/E (TTM) | 32.59 |
| Market cap | 4.92bn HKD |
| EPS (TTM) | 0.0709 HKD |
Data delayed at least 15 minutes, as of Feb 13 2026 08:08 GMT.
More ▼
Press releases
- Adventures in DMPK: Viva Biotech's One-Stop Pharmacology Platform Cross New Modalities
- Adventures in DMPK: Viva Biotech's One-Stop Pharmacology Platform Cross New Modalities
- Viva Biotech's invested and incubated company, Arthrosi, has entered into an acquisition agreement with Sobi for a total transaction value of up to US$1.5 billion.
- Viva Biotech's invested and incubated company, Arthrosi, has entered into an acquisition agreement with Sobi for a total transaction value of up to US$1.5 billion.
